Moderna

Moderna files for European authorization of updated COVID vaccine

July 3 (Reuters) - U.S. biotech firm Moderna said on Monday it had submitted a regulatory application to the European Medicines Agency (EMA) seeking authorization for its updated COVID-19 vaccine…

Read More Here

Moderna’s Omicron shots shows better immune response than original COVID vaccine

Nov 14 (Reuters) - Moderna Inc said on Monday its Omicron-tailored vaccines produced a better immune response against the BA.4/5 subvariants in a mid-to-late stage study, when given as a…

Read More Here

EU regulator recommends adding heavy periods to side effects of mRNA COVID shots

Oct 28 (Reuters) - A European Medicines Agency (EMA) committee on Friday recommended adding heavy menstrual bleeding to the list of side effect of mRNA COVID-19 vaccines made by Moderna…

Read More Here

Swiss to destroy 9 million expired Moderna COVID-19 jabs

ZURICH, Oct 19 (Reuters) - Switzerland will destroy 9 million doses of Moderna COVID-19 vaccine that have reached their expiry date, with another 5.1 million vaccine jabs set to meet…

Read More Here

Moderna signs deal on variant-adapted COVID shots for world’s poorest

LONDON, Oct 17 (Reuters) - Moderna Inc has agreed to provide its new variant-adapted COVID-19 vaccine to the global scheme aiming to deliver shots to the world's poorest people. The…

Read More Here

Pfizer, Moderna to be ready with BA.1-specific COVID boosters

(Reuters) - Pfizer Inc and Moderna Inc said they will be ready with COVID-19 vaccines designed to combat the BA.1 Omicron variant that was dominant last winter earlier than those designed to target currently…

Read More Here

Moderna booster candidate shows strong response against Omicron subvariants

June 22 (Reuters) - Moderna Inc said on Wednesday its bivalent COVID-19 booster candidate showed strong neutralizing antibody response against the fast-spreading Omicron subvariants BA.4 and BA.5. The company plans to submit applications…

Read More Here

Moderna to invest 500 mln euros in Spain

MADRID, (Reuters) - Moderna plans to invest around 500 million euros ($520.60 million) in a new laboratory in Spain to boost its production of vaccines, Spanish Prime Minister Pedro Sanchez announced. Sanchez…

Read More Here

Moderna says Omicron-specific booster generates strong immune response

June 8 (Reuters) - Moderna Inc said on Wednesday its COVID-19 vaccine booster that targets both the original coronavirus strain and Omicron produced a better immune response against the variant than its original…

Read More Here

Moderna delays COVID vaccine deliveries to EU by several months

June 2 (Reuters) - Moderna Inc said on Thursday it has agreed to push back some COVID-19 vaccine deliveries to the European Union by several months to later in 2022 or early…

Read More Here

Japan study shows women more likely to get skin rash from Moderna shot

TOKYO, June 2 (Reuters) - A study in Japan found that women were significantly more likely than men to develop rash-like side effects after a first dose of Moderna Inc's COVID-19 vaccine. The…

Read More Here

Swiss to destroy more than 620,000 expired Moderna COVID doses

ZURICH, May 27 (Reuters) - Switzerland will destroy more than 620,000 expired doses of Moderna's COVID-19 vaccine, health officials said on Friday, as demand for the shots drops dramatically. "It was consciously…

Read More Here

Booster after infection adds little extra benefit vs Omicron

Among people who were previously infected with the coronavirus, a third dose of an mRNA vaccine may not boost their protection against the Omicron variant of the virus, according to…

Read More Here

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June

Moderna Inc's chief medical officer said on Sunday the company's vaccine for children under 6 years old will be ready for review by a Food and Drug Administration panel when…

Read More Here

Moderna to file for EUA of COVID-19 shot for very young kids by April end

Moderna plans to submit an application to the U.S. health regulator for emergency use authorization (EUA) of its COVID-19 vaccine among kids between the ages of six months to five…

Read More Here

Moderna recalls thousands of COVID vaccine doses in Europe

Moderna Inc announced it was recalling 764,900 doses of its COVID-19 vaccine made by its contract manufacturer Rovi after a vial was found contaminated by a foreign body. No safety…

Read More Here

Moderna to seek regulatory approval for COVID shot for very young children

March 23 (Reuters) - Moderna Inc MRNA.O said on Wednesday it will ask regulators to authorize its COVID-19 vaccine in children younger than 6 years old based on data showing it generated a similar…

Read More Here

Moderna seeks FDA authorization for second COVID booster for all adults

Moderna Inc MRNA.O on late Thursday sought emergency use authorization from U.S. health regulators for a second COVID-19 booster shot, as a surge in cases in some parts of the world fuels…

Read More Here

Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed

BRUSSELS, Feb 17 (Reuters) - An Omicron-specific booster could be ready by August, the CEO of U.S. biotech firm Moderna MRNA.O told Reuters, but the firm is still gathering clinical data to determine whether…

Read More Here

Moderna starts trial for Omicron-specific booster shot

Moderna Inc said it had started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically designed to target the Omicron coronavirus variant, a day after rival Pfizer…

Read More Here

Moderna CEO Bancel says people may need another booster in fall of 2022

The efficacy of boosters against COVID-19 is likely to decline over the next few months and people may need another shot in the fall of 2022, Moderna Inc Chief Executive…

Read More Here

Moderna could be ready to develop Omicron booster in weeks – CEO

COVID-19 vaccine maker Moderna does not expect any problems in developing a booster shot to protect against the Omicron variant of the coronavirus and could begin work in a few weeks, Chief…

Read More Here

Moderna says booster dose of its COVID-19 vaccine appears protective against Omicron

Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant in laboratory testing and that the current version of the vaccine…

Read More Here

Moderna to produce millions of mRNA vaccines in Australia

U.S. drugmaker Moderna Inc will produce millions of mRNA vaccines a year in Australia after agreeing to set up one of its largest manufacturing facilities outside the United States and Europe. The…

Read More Here

Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response – UK study

A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks…

Read More Here

UPDATED: UK study finds mRNA COVID-19 vaccines provide biggest booster impact

LONDON, Dec 3 (Reuters) - COVID-19 vaccines made by Pfizer and Moderna that use mRNA technology provide the biggest boost to antibody levels when given 10-12 weeks after the second…

Read More Here

EXPLAINER-All U.S. adults qualify for COVID-19 boosters; which is best?

CHICAGO, Nov 20 (Reuters) - The U.S. Centers for Disease Control and Prevention on Friday expanded availability of COVID-19 booster shots to all American adults, hoping to preserve vaccine protection…

Read More Here

Germany holds onto Biontech jabs as its Moderna stock risks expiry- report

Germany’s government will limit shipments of the Biontech/PfizerCOVID-19 vaccine in the coming weeks to push the use of its stock of Moderna vaccines before it expires, a health official was…

Read More Here

FDA authorizes Moderna and Pfizer’s COVID-19 vaccine booster for U.S. adults

Nov 19 (Reuters) - The U.S. Food and Drug Administration on Friday authorized booster doses of Pfizer Inc and BioNTech SE's COVID-19 vaccine for all adults, a move aimed at…

Read More Here

EU to decide on Moderna’s COVID-19 shot for younger kids in two months

Nov 10 (Reuters) - The European Union's drug regulator expects to decide in about two months on whether to allow the use of Moderna's COVID-19 vaccine in children aged six…

Read More Here

Moderna says its COVID-19 vaccine generates immune response in young children

Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, citing interim data from a study.…

Read More Here

Sweden extends pause of Moderna COVID vaccine for younger age groups

STOCKHOLM, Oct 21 (Reuters) - Sweden has extended the pause of Moderna COVID-19 vaccine for people aged 30 and younger due to rare heart-related side-effects, the public health agency said…

Read More Here

U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost

The U.S. Food and Drug Administration authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said Americans can choose a different shot from their…

Read More Here

J&J COVID-19 shot gets better boost from Moderna or Pfizer in NIH study

People who got Johnson & Johnson Inc’s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer Inc /BioNTech SE or Moderna Inc,…

Read More Here

Moderna plans mRNA vaccine factory in Africa

Moderna plans to invest about $500 million to build a factory in Africa to make up to 500 million doses of mRNA vaccines each year, including its COVID-19 shot, as…

Read More Here

UPDATED: Finland joins Sweden and Denmark in limiting Moderna COVID-19 vaccine

Finland on Thursday paused the use of Moderna's COVID-19 vaccine for younger males due to reports of a rare cardiovascular side effect, joining Sweden and Denmark in limiting its use.…

Read More Here

Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups

STOCKHOLM, Oct 6 (Reuters) - Sweden and Denmark said on Wednesday they are pausing the use of Moderna's COVID-19 vaccine for younger age groups after reports of possible rare side…

Read More Here

UPDATED: Sweden pauses use of Moderna COVID vaccine, cites rare side effects

Sweden will pause the use of Moderna's COVID-19 vaccine for people born 1991 and later after reports of possible rare side effects, such as myocarditis, the Swedish health agency said…

Read More Here

Heart inflammation rates higher after Moderna COVID-19 vaccine – Canada data

Oct 1 (Reuters) - Canadian health officials said on Friday data suggests reported cases of rare heart inflammation were relatively higher after Moderna's COVID-19 vaccine compared with the Pfizer/BioNTech shots…

Read More Here

Italy backs COVID-19 shots for pregnant women from second trimester

MILAN (Reuters) - Italy's National Health Institute (ISS) recommended on Friday that pregnant women should get COVID-19 vaccines after the first three months of their pregnancy. The health authority said…

Read More Here

Moderna chief executive sees pandemic over in a year

Moderna Inc Chief Executive Stéphane Bancel thinks the coronavirus pandemic could be over in a year as increased vaccine production ensures global supplies, he told the Swiss newspaper Neue Zuercher…

Read More Here

Moderna says COVID-19 vaccine protection wanes, makes case for booster

New data from Moderna Inc's large COVID-19 vaccine trial shows that the protection it offers wanes over time, supporting the case for booster doses, the company said in a news…

Read More Here

WHO-backed vaccine hub for Africa to copy Moderna COVID-19 shot

Efforts to develop an African base for COVID-19 vaccine production will focus on trying to replicate Moderna's shot, but a lack of progress in talks with the U.S. company mean…

Read More Here

UPDATED: Moderna developing single-dose, combination vaccine for COVID-19, flu

Moderna Inc said on Thursday it was developing a single-dose vaccine that combines a booster dose against COVID-19 and a booster against flu. "Our number one priority as a company…

Read More Here

Japan finds another Moderna vial suspected to contain foreign substance

Japan's Kanagawa prefecture said it has found another vial of Moderna Inc's COVID-19 vaccine suspected of containing a foreign substance and has put the rest of the lot on hold.…

Read More Here

What we know about Japan’s contaminated Moderna COVID-19 vaccine supplies

Japan's COVID-19 vaccination push has been dealt a blow by widening reports of contamination in supplies of Moderna Inc's COVID-19 vaccine. Here are some key points in the issue so…

Read More Here

Japan’s Moderna vaccine contamination woes widen as 1 mln more shots withdrawn

Moderna Inc's COVID-19 vaccine contamination woes in Japan have widened with another million doses being suspended, after foreign substances were found in more batches and two people died following shots…

Read More Here

UPDATED: Two die in Japan after shots from suspended Moderna vaccines

Two people died after receiving Moderna Inc COVID-19 vaccine shots that were among lots later suspended following the discovery of contaminants, Japan's health ministry said on Saturday. The men in…

Read More Here

Contaminant in Moderna vaccines suspected to be metallic particles -NHK

A contaminant found in a batch of Moderna Inc's COVID-19 vaccines delivered to Japan is believed to be a metallic particle, Japanese public broadcaster NHK reported, citing sources at the…

Read More Here

EU investigating Moderna vaccine contamination incident

The European Medicines Agency (EMA) said it was investigating a contamination incident in the manufacturing of Moderna COVID-19 vaccines to assess whether there was an impact on EU supply. Japan…

Read More Here

Spain’s Rovi says possible Moderna vaccine contamination under investigation

Spanish pharma company Rovi said on Thursday the potential contamination of some doses of the coronavirus vaccine which it manufactures for Moderna was under investigation and appeared limited to some…

Read More Here

UPDATED: Moderna withholds 1.63 mln COVID-19 vaccine doses in Japan due to contamination

Japan suspended the use of 1.63 million doses of Moderna Inc's COVID-19 vaccine on Thursday, more than a week after the domestic distributor received reports of contaminants in some vials.…

Read More Here

U.S. probing Moderna vaccine for higher heart inflammation risk

U.S. health officials are investigating reports that Moderna Inc's COVID-19 vaccine may be linked to a higher risk of a rare heart condition in younger adults than previously thought, the…

Read More Here

Moderna says its COVID-19 shot remains 93% effective 4-6 months after second dose

Moderna Inc said on Thursday its COVID-19 shot was about 93% effective four to six months after the second dose, showing hardly any change from the 94% efficacy reported in…

Read More Here

Pfizer and Moderna raise prices for COVID-19 vaccines in EU- FT

(Reuters) -Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday. The new price…

Read More Here

Italian regulator endorses Moderna COVID-19 vaccine for teens

Italian regulators approved the use of Moderna's COVID-19 vaccine for children 12-17 years old, making it the second shot endorsed for adolescents, alongside that of Pfizer. Italian drug agency AIFA…

Read More Here

South Korea says Moderna reports ‘production issue’

South Korea said on Monday it has been informed by Moderna of an unspecified production issue involving its COVID-19 vaccine, as the country expands its inoculation campaign for people aged…

Read More Here